FDA Inspection 1219707 - Boehringer Ingelheim Pharmaceuticals, Inc. - September 22, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on September 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date: September 22, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 119b61c4-4cb0-4efb-bddf-d360ea05cf99